Nicotinamide riboside (NR) is a form of vitamin B3 that your body converts into NAD+, a molecule every cell needs to produce energy, repair DNA, and carry out hundreds of essential reactions. NAD+ levels naturally decline with age, and NR supplements are marketed as a way to restore them. The reality, based on human clinical trials, is more nuanced than the marketing suggests.
How NR Becomes NAD+ in Your Cells
Once you swallow NR, it enters what’s called the NAD+ salvage pathway. Enzymes called nicotinamide riboside kinases (NRK1 and NRK2) add a phosphate group to NR, turning it into an intermediate called NMN. A second enzyme then attaches another chemical group to produce the finished NAD+ molecule. This two-step process (phosphorylation, then adenylylation) is efficient enough that oral NR supplementation reliably raises blood NAD+ levels in humans.
The timeline matters if you’re taking it. After a single dose, blood levels of the raw material peak within about 30 minutes. NAD+ itself takes longer to build up, reaching its maximum concentration around 12 hours after ingestion. With daily supplementation, sustained increases in NAD+ typically appear within a few weeks. A long-COVID trial measured significant NAD+ increases after five weeks of daily use.
What Higher NAD+ Is Supposed to Do
The appeal of boosting NAD+ comes down to a family of proteins called sirtuins. These proteins act as cellular maintenance crews: they help repair damaged DNA, defend against oxidative stress, and regulate how mitochondria (your cells’ power generators) function. Sirtuins need NAD+ as fuel. When NAD+ drops, sirtuin activity drops with it, and protective pathways start to falter. The theory behind NR supplementation is simple: restore NAD+, reactivate sirtuins, slow down the cellular deterioration that comes with aging.
That theory has strong support in animal models. In yeast, the NRK pathway promotes replicative lifespan. In mice, NR supplementation has improved metabolic health, muscle stem cell function, and neurological markers. The question is how much of this translates to humans.
What Human Trials Actually Show
Muscle and Mitochondria
The strongest human evidence for NR comes from a twin study published in Science Advances. Twenty pairs of identical twins took escalating doses of NR (building up to 1,000 mg per day) for five months. Muscle biopsies revealed that NR increased mitochondrial density in muscle fibers by roughly 14%, and mitochondrial DNA content jumped by about 30%. The supplement also activated a chain of proteins involved in building new mitochondria.
NR also appeared to push muscle stem cells (satellite cells) toward maturation. Muscle samples from the supplemented twins showed fewer dormant stem cells but more signs of active differentiation and fusion into existing muscle fibers. This suggests NR may help with muscle maintenance and repair, though the study didn’t measure real-world outcomes like strength or recovery time.
Cardiovascular and Metabolic Health
Results here have been disappointing. A clinical trial of 40 sedentary obese men taking 2,000 mg of NR daily found no effect on insulin sensitivity, body composition, skeletal muscle NAD+ metabolites, or mitochondrial activity. Blood pressure and inflammatory markers have also remained unchanged across multiple studies.
Brain Function and Cognition
A randomized controlled trial in people with long-COVID tested whether NR could improve cognitive symptoms. The primary outcome was clear: no significant difference in cognition between the NR and placebo groups. Exploratory analyses hinted at improvements in executive function, fatigue, sleep quality, and depressive symptoms after 10 weeks of NR, but these weren’t the pre-specified endpoints, so they should be treated as preliminary signals rather than conclusions.
The Heart Tissue Problem
One of the more surprising findings came from research on cardiac tissue. In a study on mice with heart damage, NR supplementation failed to increase NAD+ levels in the heart and did not improve sirtuin activity there. High doses actually backfired, increasing protein acetylation (the opposite of what sirtuins do). The likely explanation: excess NR gets broken down into nicotinamide, which at high concentrations inhibits the very sirtuin enzymes NR is supposed to support. This raises important questions about whether more is better with NR supplementation.
How NR Compares to NMN
NR and NMN are the two most popular NAD+ precursor supplements, and they’re closely related. NMN is actually one step closer to NAD+ in the biochemical pathway. However, there’s an ongoing debate about whether NMN can enter cells directly or whether it first needs to be converted back into NR outside the cell before being taken up. Some research suggests NMN is broken down into NR by enzymes on cell surfaces, meaning both supplements may ultimately enter cells the same way.
NR has its own stability issues. It degrades quickly into plain nicotinamide in blood plasma, which means much of an oral dose may never reach tissues as intact NR. Neither supplement has been detected in its original form inside human blood cells after supplementation, likely because both are rapidly converted once absorbed. The pharmacokinetics of both compounds are still being worked out, and head-to-head human trials comparing their effectiveness are limited.
Dosage and Safety
Most human trials have used between 250 mg and 2,000 mg of NR per day, with 1,000 mg being the most common dose. NR has been well tolerated up to 2,000 mg daily across multiple studies, with no serious adverse effects reported. Unlike niacin (another form of vitamin B3), NR does not cause flushing, the uncomfortable skin reddening and warmth that makes high-dose niacin difficult for many people. No liver damage, blood sugar spikes, or elevated uric acid have been observed in clinical settings.
In the United States, NR is sold as a dietary supplement. It has been submitted to the FDA through the New Dietary Ingredient notification process, with the most recent filing reviewed in April 2025. It is not approved as a drug for any condition.
The Gap Between Promise and Proof
NR reliably raises NAD+ levels in blood. It increases mitochondrial density in skeletal muscle. It pushes muscle stem cells toward differentiation. These are real, measurable biological effects confirmed in human tissue. But the leap from “changes biomarkers” to “improves health outcomes” hasn’t been made convincingly yet. Blood pressure, body composition, insulin sensitivity, inflammation, and cognition have all remained stubbornly unchanged in controlled human trials.
The cardiac tissue findings also introduce a genuine concern: at high doses, NR may generate enough nicotinamide to actually inhibit the sirtuin activity it’s supposed to enhance. This doesn’t mean NR is dangerous at standard doses, but it does suggest a ceiling effect where more supplementation could become counterproductive. For now, NR sits in a familiar spot for anti-aging supplements: compelling biology, modest human evidence, and a lot of unanswered questions about who benefits, at what dose, and over what timeframe.